Addenda Capital Inc. boosted its position in shares of Colgate-Palmolive (NYSE:CL) by 6.1% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 15,226 shares of the company’s stock after acquiring an additional 876 shares during the period. Addenda Capital Inc.’s holdings in Colgate-Palmolive were worth $1,044,000 as of its most recent SEC filing.

A number of other large investors have also recently modified their holdings of the stock. HighPoint Advisor Group LLC increased its stake in Colgate-Palmolive by 2.5% in the fourth quarter. HighPoint Advisor Group LLC now owns 7,799 shares of the company’s stock valued at $520,000 after acquiring an additional 193 shares during the last quarter. Cerity Partners LLC boosted its holdings in shares of Colgate-Palmolive by 3.7% in the 4th quarter. Cerity Partners LLC now owns 5,466 shares of the company’s stock worth $325,000 after purchasing an additional 197 shares in the last quarter. Curbstone Financial Management Corp boosted its holdings in shares of Colgate-Palmolive by 1.2% in the 4th quarter. Curbstone Financial Management Corp now owns 16,870 shares of the company’s stock worth $1,093,000 after purchasing an additional 200 shares in the last quarter. Pinnacle Wealth Management Advisory Group LLC increased its position in shares of Colgate-Palmolive by 5.3% during the 4th quarter. Pinnacle Wealth Management Advisory Group LLC now owns 3,982 shares of the company’s stock valued at $237,000 after purchasing an additional 200 shares during the last quarter. Finally, JOYN Advisors Inc. raised its holdings in shares of Colgate-Palmolive by 18.0% during the 4th quarter. JOYN Advisors Inc. now owns 1,316 shares of the company’s stock valued at $78,000 after buying an additional 201 shares in the last quarter. 76.13% of the stock is owned by institutional investors.

Shares of Colgate-Palmolive stock opened at $68.11 on Wednesday. The company has a current ratio of 1.14, a quick ratio of 0.76 and a debt-to-equity ratio of 32.25. Colgate-Palmolive has a 52-week low of $57.41 and a 52-week high of $72.61. The company has a market capitalization of $58.40 billion, a PE ratio of 22.93, a PEG ratio of 4.39 and a beta of 0.79.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings results on Friday, January 25th. The company reported $0.74 EPS for the quarter, beating the Zacks’ consensus estimate of $0.73 by $0.01. The company had revenue of $3.81 billion during the quarter, compared to analyst estimates of $3.78 billion. Colgate-Palmolive had a net margin of 15.44% and a return on equity of 25,268.29%. The firm’s revenue was down 2.1% compared to the same quarter last year. During the same period in the prior year, the business posted $0.75 EPS. As a group, analysts predict that Colgate-Palmolive will post 2.83 EPS for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Friday, April 19th will be given a $0.43 dividend. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.42. The ex-dividend date of this dividend is Wednesday, April 17th. This represents a $1.72 dividend on an annualized basis and a dividend yield of 2.53%. Colgate-Palmolive’s payout ratio is presently 56.57%.

CL has been the subject of a number of recent research reports. Zacks Investment Research upgraded Colgate-Palmolive from a “sell” rating to a “hold” rating in a research report on Thursday, January 10th. Morgan Stanley set a $62.00 price target on shares of Colgate-Palmolive and gave the stock a “hold” rating in a research note on Tuesday, January 29th. UBS Group boosted their price objective on shares of Colgate-Palmolive from $71.00 to $75.00 and gave the stock a “buy” rating in a report on Friday, March 29th. BNP Paribas raised shares of Colgate-Palmolive from an “underperform” rating to a “neutral” rating and upped their price objective for the company from $56.00 to $67.00 in a research note on Monday, February 11th. Finally, Wells Fargo & Co reaffirmed a “hold” rating and issued a $57.00 price objective on shares of Colgate-Palmolive in a research note on Friday, January 25th. Three analysts have rated the stock with a sell rating, twelve have given a hold rating and four have assigned a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and an average target price of $65.73.

In other news, VP Justin Skala sold 4,488 shares of the business’s stock in a transaction that occurred on Tuesday, February 19th. The stock was sold at an average price of $66.39, for a total transaction of $297,958.32. Following the transaction, the vice president now directly owns 71,010 shares of the company’s stock, valued at $4,714,353.90. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, CTO Patricia Verduin sold 2,218 shares of the business’s stock in a transaction that occurred on Tuesday, February 19th. The shares were sold at an average price of $66.38, for a total value of $147,230.84. Following the transaction, the chief technology officer now directly owns 48,671 shares in the company, valued at $3,230,780.98. The disclosure for this sale can be found here. Insiders sold 85,450 shares of company stock worth $5,682,621 in the last 90 days. Corporate insiders own 1.02% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: “Addenda Capital Inc. Has $1.04 Million Stake in Colgate-Palmolive (CL)” was published by Watch List News and is owned by of Watch List News. If you are viewing this piece on another publication, it was illegally copied and republished in violation of U.S. and international copyright laws. The original version of this piece can be viewed at https://www.watchlistnews.com/addenda-capital-inc-has-1-04-million-stake-in-colgate-palmolive-cl/2951927.html.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners.

Read More: Lock-Up Period Expiration

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.